PACB Pacific Biosciences of California
Company Analysis
Latest News
🟢 Pacific Biosciences is trading 5.4% up today amid biotech sector strength and market rally
Pacific Biosciences is trading 5.4% up at $1.48, moving in line with a strong risk-on session in U.S. equities and a broader rally across the biotechnology...
🔴 Pacific Biosciences is trading 5% down today on light, news-less trading
Pacific Biosciences is trading 5% down at $1.33 on light, news-less trading. • The move appears to be driven by idiosyncratic volatility following recent...
🔴 Pacific Biosciences is trading 5.5% down today as multi-day slide continues after weak Q1 results
Pacific Biosciences is trading 5.5% down at $1.36 as the stock extends a multi-day slide following a weak first-quarter earnings report and revenue...
🔴 Pacific Biosciences is trading 5.3% down today following the resignation of board member Christopher M. Smith
Pacific Biosciences is trading 5.3% down today at $1.52 after investors reacted to the sudden resignation of board member Christopher M. Smith, announced on...
PACB Announces Resignation of Board Member Christopher M. Smith
Pacific Biosciences of California, Inc. (PACB) announced that Christopher M. Smith, a member of its board of directors, has resigned from the Board, effective...
🟢 Pacific Biosciences is trading 10.3% up
Pacific Biosciences is trading at $1.66, up 10.3% from a comparison close of $1.50 during regular trading. This is a price-action follow-up, so a separate...
PacBio Bounces 9% Off Its Lows, but Can a Gene-Sequencing Company Burning Cash Outrun a Shrinking Revenue Ceiling?
Shares of Pacific Biosciences shifted sharply higher on July 9, rising 9% to $1.64 after touching $1.50 the prior session — a slide that capped a week-long...
🟢 Pacific Biosciences is trading 7.67% up today as it rebounds from a selloff following a revenue guidance cut
Pacific Biosciences is trading at $1.64 (+7.67%) as the stock stages a sharp rebound from the previous session's selloff. • The recent downward pressure...
🔴 PACB is trading 5.1% down today on lowered 2026 guidance and small-cap biotech volatility
PACB is trading 5.1% down at $1.48 amid continued volatility in small-cap biotech and lingering reaction to its mixed Q1 2026 results. • Recent coverage...
🔴 PACB is trading 5.7% down today amid continued small-cap biotech volatility
PACB is trading 5.7% down today at $1.56 as the stock experiences continued volatility typical of thinly traded small-cap biotech names. • There is no fresh...